First Tracks Biotherapeutics, Inc. · NASDAQ:TRAX

EcoR1 Capital, LLC reported a 9.10% stake in First Tracks Biotherapeutics, Inc. (Schedule 13G)

Event Apr 20, 2026 · Filed Apr 22, 2026

EcoR1 Capital, LLC reported a 9.10% stake in First Tracks Biotherapeutics, Inc., 3,174,519 shares, as a passive investor on Apr 20, 2026. Filed Apr 22, 2026 (Schedule 13G).

Stake
9.10%
Shares
3,174,519
Intent
Passive
What changed
Crossed above 5%
Filed together
3 holders

The filing in full

HolderStakeShares
EcoR1 Capital, LLC9.10%3,174,519
Oleg Nodelman9.10%3,174,519
EcoR1 Capital Fund Qualified, L.P.8.50%2,981,908

Source

View original at SEC

Related